TY - JOUR

T1 - Stress hormone dynamics are coupled to brain serotonin 4 receptor availability in unmedicated patients with Major Depressive Disorder - a NeuroPharm study

AU - Vulpius, Gunild M

AU - Köhler-Forsberg, Kristin

AU - Ozenne, Brice

AU - Larsen, Søren V

AU - Nasser, Arafat

AU - Svarer, Claus

AU - Gillings, Nic

AU - Keller, Sune H

AU - Jørgensen, Martin B

AU - Knudsen, Gitte M

AU - Frokjaer, Vibe G

N1 - © The Author(s) 2023. Published by Oxford University Press on behalf of CINP.

PY - 2023

Y1 - 2023

N2 - BACKGROUND: A prominent finding in Major Depressive Disorder (MDD) is distorted stress hormone dynamics, which is regulated by serotonergic brain signaling. An interesting feature of the cerebral serotonin system is the serotonin 4 receptor (5-HT4R), which is lower in depressed relative to healthy individuals, and also has been highlighted as a promising novel antidepressant target. Here, we test the novel hypothesis that brain 5-HT4R availability in untreated patients with MDD is correlated with cortisol dynamics, indexed by the cortisol awakening response (CAR). Further, we evaluate if CAR changes with antidepressant treatment including selective serotonin reuptake inhibitor, and if pretreatment CAR can predict treatment outcome.METHODS: Sixty-six patients (76% women) with a moderate to severe depressive episode underwent positron emission tomography (PET) imaging with [ 11C]SB207145 for quantification of brain 5-HT4R binding using BPND as outcome. Serial home sampling of saliva in the first hour from awakening was performed to assess CAR before and after 8 weeks of antidepressant treatment. Treatment outcome was measured by change in Hamilton Depression Rating Scale 6 items.RESULTS: In the unmedicated depressed state, prefrontal and anterior cingulate cortices 5-HT4R binding was positively associated with CAR. CAR remained unaltered after 8 weeks of antidepressant treatment, and pretreatment CAR did not significantly predict treatment outcome.CONCLUSIONS: Our findings highlight a link between serotonergic disturbances in MDD and cortisol dynamics which likely is involved in disease- and treatment mechanisms. Further, our data support 5-HT4R agonism as a promising precision target in patients with MDD and disturbed stress hormone dynamics.

AB - BACKGROUND: A prominent finding in Major Depressive Disorder (MDD) is distorted stress hormone dynamics, which is regulated by serotonergic brain signaling. An interesting feature of the cerebral serotonin system is the serotonin 4 receptor (5-HT4R), which is lower in depressed relative to healthy individuals, and also has been highlighted as a promising novel antidepressant target. Here, we test the novel hypothesis that brain 5-HT4R availability in untreated patients with MDD is correlated with cortisol dynamics, indexed by the cortisol awakening response (CAR). Further, we evaluate if CAR changes with antidepressant treatment including selective serotonin reuptake inhibitor, and if pretreatment CAR can predict treatment outcome.METHODS: Sixty-six patients (76% women) with a moderate to severe depressive episode underwent positron emission tomography (PET) imaging with [ 11C]SB207145 for quantification of brain 5-HT4R binding using BPND as outcome. Serial home sampling of saliva in the first hour from awakening was performed to assess CAR before and after 8 weeks of antidepressant treatment. Treatment outcome was measured by change in Hamilton Depression Rating Scale 6 items.RESULTS: In the unmedicated depressed state, prefrontal and anterior cingulate cortices 5-HT4R binding was positively associated with CAR. CAR remained unaltered after 8 weeks of antidepressant treatment, and pretreatment CAR did not significantly predict treatment outcome.CONCLUSIONS: Our findings highlight a link between serotonergic disturbances in MDD and cortisol dynamics which likely is involved in disease- and treatment mechanisms. Further, our data support 5-HT4R agonism as a promising precision target in patients with MDD and disturbed stress hormone dynamics.

U2 - 10.1093/ijnp/pyad041

DO - 10.1093/ijnp/pyad041

M3 - Journal article

C2 - 37542733

VL - 26

SP - 639

EP - 648

JO - International Journal of Neuropsychopharmacology

JF - International Journal of Neuropsychopharmacology

SN - 1461-1457

IS - 9

ER -